Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy

scientific article published on 27 March 2019

Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1113006801
P356DOI10.1186/S40345-019-0145-0
P932PMC publication ID6435763
P698PubMed publication ID30915592

P50authorSameer JauharQ57013497
P2093author name stringAllan H Young
P2860cites workReal-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.Q53272906
Bipolar disordersQ59209509
Areas of uncertainties and unmet needs in bipolar disorders: clinical and research perspectivesQ62842088
Is clozapine a mood stabilizer?Q72614469
THE USE OF LITHIUM SALTS IN AFFECTIVE DISORDERSQ76609750
Bipolar treatment efficacyQ86116331
Timing of onset of lithium relapse prevention in bipolar disorder: evidence from randomised trialsQ91676491
A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequentlyQ43239518
PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodiumQ43977655
A proposal for an updated neuropsychopharmacological nomenclatureQ44009538
Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-AnalysisQ44435116
Importance of Psychiatric Diagnosis in Prediction of Clinical Drug EffectsQ44993702
Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study GroupQ45338046
The long-term natural history of the weekly symptomatic status of bipolar I disorderQ46317822
Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I DisorderQ47758943
Quetiapine v. lithium in the maintenance phase following a first episode of mania: randomised controlled trialQ47786827
Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial.Q48068105
A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorderQ48697520
Reasons for lithium discontinuation in men and women with bipolar disorder: a retrospective cohort study.Q49769657
A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and SchizophreniaQ50096180
The Northwick Park "functional" psychosis study: diagnosis and treatment response.Q51186898
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.Q52656684
The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmQ28066714
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogeneticsQ28081249
Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysisQ28245879
Polarity index of pharmacological agents used for maintenance treatment of bipolar disorderQ28250466
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trialQ28259736
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysisQ28293647
Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial.Q30490025
Effectiveness of antipsychotics used in first-episode psychosis: a naturalistic cohort study.Q30490166
Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory dataQ30957546
The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatmentQ33593061
Global burden of disease in young people aged 10-24 years: a systematic analysisQ34190586
LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDYQ34515834
Treatment non-adherence in affective disorders.Q34592227
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorderQ34649187
Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysisQ34661011
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyQ34676317
Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysisQ34744822
The suicide prevention effect of lithium: more than 20 years of evidence-a narrative reviewQ35858926
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disordersQ35862776
Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysisQ36286584
Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health recordsQ36657853
Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar DisorderQ37152810
The 'atypicality' of antipsychotics: a concept re-examined and re-definedQ37391972
Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trialsQ37451403
Effects of lithium on cognitive performance: a meta-analysisQ37582048
Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic reviewQ38131169
"First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effectsQ38291338
Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal StudyQ38381456
Recovery and recurrence following a first episode of mania: a systematic review and meta-analysis of prospectively characterized cohortsQ38407076
Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis.Q38584955
Three-year clinical and functional outcome comparison between first-episode mania with psychotic features and first-episode schizophreniaQ38815601
Long-Acting Injectable Antipsychotics for Prevention of Relapse in Bipolar Disorder: A Systematic Review and Meta-Analyses of Randomized Controlled Trials.Q38840490
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.Q42625302
Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorderQ43130555
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectbipolar disorderQ131755
P304page(s)10
P577publication date2019-03-27
P1433published inInternational journal of bipolar disordersQ27725397
P1476titleControversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy
P478volume7